Grasiele S.V. Tavares

Author

Universidade Federal de Minas Gerais

Also Known As

Grasiele S. V. Tavares, Grasiele S.V. Tavares, Grasiele Tavares, Lourena Costa

Publications

855

Citations

H-Index

Concepts

All Affiliations

Universidade Federal de Minas Gerais Universidade Federal de Ouro Preto Universidade do Extremo Sul Catarinense Catholic University of Santa María Southampton General Hospital

About

Grasiele S.V. Tavares is an author at Universidade Federal de Minas Gerais specializing in medicine, parasitology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	27	507
2	Natural Sciences	3	3	50
3	Biochemistry	2	2	39
4	Engineering	1	1	11
5	Allergy	1	1	24

Grasiele S.V. Tavares

Publications

709

Citations

H-Index

Page 1

	Year	Citations
A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection Daniela P. Lage, Patrícia A.F. Ribeiro, Daniel Dias, npj Vaccines	2020	47
Antileishmanial activity and mechanism of action from a purified fraction of Zingiber officinalis Roscoe against Leishmania amazonensis Mariana C. Duarte, Grasiele S.V. Tavares, Diogo G. Valadares, Experimental Parasitology Antileishmanial ActivityAntiparasitic AgentMedicineParasitic ProtozoaParasite Control	2016	45
In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic® F127-based polymeric micelle system against Leishmania amazonensis infection Débora V.C. Mendonça, Grasiele S.V. Tavares, Daniela P. Lage, Biomedicine & Pharmacotherapy	2018	31
A clioquinol-containing Pluronic<sup>®</sup> F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model Grasiele S.V. Tavares, Débora V.C. Mendonça, Isabela A.G. Pereira, Parasite	2020	30
A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection Grasiele S.V. Tavares, Débora V.C. Mendonça, Carolina K. Miyazaki, Parasitology International Antileishmanial MoleculeAntiparasitic AgentMedicineParasitic ProtozoaImmunology	2018	29
Recombinant Leishmania eukaryotic elongation factor-1 beta protein: A potential diagnostic antigen to detect tegumentary and visceral leishmaniasis in dogs and humans Thaís T.O. Santos, Mariana Santos Cardoso, Amanda S. Machado, Microbial Pathogenesis Parasitic ProtozoaMedicinePathogenesisImmunologyPathology	2019	28
A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection Daniela P. Lage, Danniele L. Vale, Flávia P. Linhares, Vaccines Nitric OxideImmunologyImmune RegulationImmunodominanceLicensed Vaccine	2022	28
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis Daniela P. Lage, Patrícia A.F. Ribeiro, Daniel Dias, Vaccines	2020	27
Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection Patrícia A.F. Ribeiro, Daniel Dias, Daniela P. Lage, Molecular Immunology VaccinationLeishmania Infantum InfectionProtective EfficacyParasitic ProtozoaMedicine	2018	26
Screening diagnostic candidates from<i>Leishmania infantum</i>proteins for human visceral leishmaniasis using an immunoproteomics approach Daniela P. Lage, Fernanda Ludolf, Amanda S. Machado, Parasitology Parasitic DiseaseImmunologyPathologyImmunoproteomics ApproachImmunotherapy	2019	24

Page 1